HR+ HER2- Breast Cancer
Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2023 ASCO Annual Meeting
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Breast Cancer presented at this year’s ASCO Annual Meeting.
VIEW THE TOPICS
- CDK4/6 Inhibition in Early-Stage and Advanced HR+ Breast Cancer
- HR+ Breast Cancer—Local/Regional/Adjuvant Therapy Updates
- HR+/HER2- Breast Cancer: Conference Highlights
- SERMs and SERDs in Breast Cancer: Where Do We Stand?
This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.